stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Eton Pharmaceuticals, Inc. (ETON)
- Amphastar Pharmaceuticals, Inc. AMPH 27.59 −1.53%
- Eton Pharmaceuticals, Inc. ETON 47.45 −6.45%
Amphastar Pharmaceuticals, Inc. and Eton Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Eton Pharmaceuticals, Inc. is the larger, with a market value of $1.4B against $1.2B — 1.1× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 12.3× against 26.8×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 100.6% against 3.11%. Eton Pharmaceuticals, Inc. has the higher net margin (35.4% vs 13.3%) and the higher return on invested capital (46.8% vs 6.12%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 11 and Eton Pharmaceuticals, Inc. on 11.
Valuation
Profitability
| Metric | AMPH | ETON | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 69.15% | 53.51% |
| Operating margin | 18.74% | 28.84% | 0.00% |
| Net margin | 13.27% | 35.35% | (2.45%) |
| Free cash flow margin | 18.64% | 14.17% | 0.00% |
| Return on equity | 12.44% | 90.62% | (0.80%) |
| Return on assets | 5.86% | 38.10% | (1.67%) |
| Return on invested capital | 6.12% | 46.77% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack